What is Organogenesis Holdings Inc.'s EBITDA margin?

Organogenesis Holdings Inc. (ORGO) reported EBITDA margin of 3.6% in Q1 2026.

What is the long-term trend for Organogenesis Holdings Inc.'s EBITDA margin?

Over 3 years (2020 to 2025), Organogenesis Holdings Inc.'s EBITDA margin has grown at a 1.0% compound annual growth rate (CAGR), from 10.3% to 10.6%.

What does EBITDA margin mean?

EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Organogenesis Holdings Inc. ORGO EBITDA margin

EBITDA margin at other companies

IAR

Integra LifeSciencesIART

-19.5%-30.1pp

MiMedx GroupMDXG

13.1%-4.5pp

Orthofix Medical Inc.OFIX

-3%-1.1pp

BioventusBVS

18%+14.9pp

ArtivionAORT

13.2%+3.1pp

AxogenAXGN

-1%—

Other financials

Income statement

See full

Revenue$37.2M-57.1%

Gross profit$63.0M-22.5%

Operating income-$68.9M-158%

Net income-$53.2M-182%

EPS (diluted)-$0.44-159%

Balance sheet

See full

Cash & equivalents$91.4M-16.9%

Total debt$39.4M+24.8%

Total equity$244.6M+0.7%

Total assets$520.0M+11.3%

Cash flow

See full

Operating cash flow$21.1M+206%

CapEx$3.1M-13.2%

Free cash flow$18.0M+176%

Valuation

See full

Market cap$312.68M-23.7%

Enterprise value$260.72M-21.3%

P/E115×—

P/S0.6×-0.3×

Profitability

See full

Gross margin75.9%+0.8pp

Operating margin0.5%—

Net margin0.5%+0.3pp

FCF margin6.9%—

Returns & leverage

See full

Return on equity1.1%+0.6pp

Debt / equity0.2×0.0×

Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

ebitda/total revenue=3.6%

Based on trailing twelve months.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s EBITDA margin?: Organogenesis Holdings Inc. (ORGO) reported EBITDA margin of 3.6% in Q1 2026.
What is the long-term trend for Organogenesis Holdings Inc.'s EBITDA margin?: Over 3 years (2020 to 2025), Organogenesis Holdings Inc.'s EBITDA margin has grown at a 1.0% compound annual growth rate (CAGR), from 10.3% to 10.6%.
What does EBITDA margin mean?: EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.